Product Reports Resources Pricing Login Book a demo

Sight Diagnostics

Biotech & Life Sciences · Bnei Brak, Israel · Founded 2011

Sight Diagnostics is a medical device company bringing affordable, accurate diagnostics to the point-of-care MoreLess

Sight Diagnostics, the company behind Sight OLO, operates in the healthcare technology market, providing innovative solutions for blood testing. The company's flagship product, Sight OLO, is a high-performance complete blood count (CBC) analyzer that delivers accurate results within minutes. This product is FDA 510(k) cleared for use in moderately complex laboratories, making it a reliable tool for healthcare providers.

Sight OLO's primary clients are healthcare practices that require quick and accurate blood test results. The device is easy to use and doesn't require calibration or maintenance, making it a practical choice for busy healthcare environments. It uses a small blood sample, either from a finger prick or venous draw, and processes the results in minutes. This quick turnaround time allows healthcare providers to make immediate treatment decisions, reducing patient anxiety and potentially improving health outcomes.

The business model of Sight Diagnostics is based on the sale of the Sight OLO device to healthcare providers. The company generates revenue from the sale of these devices, which are designed to streamline the workflow of healthcare practices and improve patient care.

Sight Diagnostics has been recognized for its innovative approach, being named one of the 2021 CNBC Disruptor 50 Companies, a 2021 Bronze Winner, and receiving an honorable mention in the 2021 World Changing Ideas Awards. It was also a quarterfinalist in the 2020 UCSF Digital Health Awards.

Keywords: Healthcare Technology, Blood Testing, Complete Blood Count Analyzer, FDA 510(k) Cleared, Easy-to-Use, Quick Results, Healthcare Providers, Streamlined Workflow, Innovative Approach, Award-Winning.

Company overview

Sight Diagnostics company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2011
Headquarters
Bnei Brak, Israel
Employees
66
Open positions
None listed
Dealroom signal
64.4
sub industryBioTechnologysub industryMedical Devicesbusiness modelManufacturingsectorTestingindustryHealthsectorData AnalyticssectorBiotechnologysectorMedical ImagingsectorCore AIsectorHealth DiagnosticssectorTech for Hospitals and ClinicssectorClinical Decision SupportsectorHard TechsectorAI Applications

Valuation & funding

Sight Diagnostics funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Jul 2020 $12M $47M OurCrowd
SERIES DOther financing Jul 2020 $71M $284M Clal Biotechnology Industries
SERIES COther financing Feb 2019 $28M $111M OurCrowd · GO Capital · Steve Erick · Longliv Ventures
LATE VCOther financing Dec 2018 $5.3M $21M OurCrowd
LATE VCOther financing Nov 2016 $3.1M $13M OurCrowd
SERIES BOther financing Sep 2016 Undisclosed
SERIES BOther financing Jan 2016 GEOC - China-Israel fund · New Alliance Capital · OurCrowd
SERIES AOther financing Nov 2014 Innovation Endeavors · Clal Biotechnology Industries · OurCrowd · Emery Capital
SEEDOther financing Apr 2014 OurCrowd
SEEDOther financing Aug 2011 OurCrowd · Moshe Yanai
Showing 10 recorded eventsUnlock the complete deal history →

Growth signals

Sight Diagnostics website traffic

Latest recorded traffic for Sight Diagnostics is 1.1K monthly website visits, up 100% over the last three months. Sight Diagnostics's team declined 1.5% over the past year.

Latest monthly visits1.1K 3-month web change+100% 1-year team growth-1.5%
Monthly website visits128 observations · Jun 2015–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Sight Diagnostics compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Sight Diagnostics's talent

Book a demo to see the people
Team profiled 21 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

11 investors on Sight Diagnostics's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 2 investors entered at this stage
OurCrowd
Moshe Yanai
Series A 5 investors entered at this stage
Innovation Endeavors
Clal Biotechnology Industries
Emery Capital
GEOC - China-Israel fund
New Alliance Capital
Series B+ 4 investors entered at this stage
Longliv Ventures
GO Capital
Steve Erick
Jack Nicklaus II

Global footprint

Where Sight Diagnostics has talent and traffic

Workforce by country
3 countries with
team presence
🇮🇱 Israel95.2%
🇦🇺 Australia2.4%
🇸🇬 Singapore2.4%
3 countries shown

In the news

Latest news about Sight Diagnostics

Recent press, funding announcements, and product moves mentioning Sight Diagnostics — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Sight Diagnostics

An AI-synthesized read of the highest-engagement posts about Sight Diagnostics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sight Diagnostics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.